An Intervention Study of Shaanxi Fucha on Prevention and Treatment of Cardiovascular Diseases

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047294

Enrollment

Unknown

Registered

2021-06-11

Start date

2021-06-11

Completion date

Unknown

Last updated

2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

Control group1:None

Experimental group1:Jingwei Fucha 10g/d

Control group2:Basic medication

Experimental group2:Basic medication and Jingwei Fucha 10g/d

Eligibility

Sex/Gender

All

Age

35 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Recruit subjects aged 35 to 60 years, male or female, with eating habits in Guanzhong region, low mobility, and able to complete the three-month intervention study; 2.Patients with definite diagnosis of CHD, aged 50 to 65 years, male or female, who can complete the 3-month intervention study.

Exclusion criteria

Exclusion criteria: 1.Women who are pregnant and lactating; 2.Have taken prebiotics or probiotics or bibiotics preparations within the last 1 month; 3.Have taken antibiotics in the last 3 months; 4.The person who is allergic to indigo tea.

Design outcomes

Primary

Measure	Time frame
Gut microbiota;Flora metabolites;	—

Countries

China

Contacts

Public ContactWang Junkui

Shaanxi Provincial People's Hospital

cardiowang@163.com+86 13519186905

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026